Keynote 057: Phase II trial of Pembrolizumab (pembro) for patients (pts) with high-risk (HR) nonmuscle invasive bladder cancer (NMIBC) unresponsive to bacillus calmette-guerin (BCG).

被引：68
|
作者：
Balar, Arjun Vasant
Kulkarni, Girish S.
Uchio, Edward M.
Boormans, Joost
Mourey, Loic
Krieger, Laurence Eliot Miles
Singer, Eric A.
Bajorin, Dean F.
Kamat, Ashish M.
Grivas, Petros
Seo, Ho Kyung
Nishiyama, Hiroyuki
Konety, Badrinath R.
Nam, Kijoeng
Kapadia, Ekta
Frenkl, Tara L.
De Wit, Ronald
机构：
[1] NYU Langone Hlth, Perlmutter Canc Ctr, New York, NY USA
[2] Univ Toronto, UHN Princess Margaret Canc Ctr, Toronto, ON, Canada
[3] UC Irvine Hlth, Orange, CA USA
[4] Erasmus MC, Rotterdam, Netherlands
[5] Inst Univ Canc Toulouse Oncopole, Toulouse, France
[6] Royal North Shore Hosp, Northern Canc Inst, St Leonards, NSW, Australia
[7] Rutgers Canc Inst New Jersey, Sect Urol Oncol, New Brunswick, NJ USA
[8] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[9] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[10] Univ Washington, Seattle, WA 98195 USA
[11] Natl Canc Ctr, Goyang, South Korea
[12] Univ Tsukuba, Tsukuba, Ibaraki, Japan
[13] Univ Minnesota, Minneapolis, MN USA
[14] Merck & Co Inc, Kenilworth, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 07期
关键词：
D O I：
10.1200/JCO.2019.37.7_suppl.350
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
350
引用
收藏
页数：2
相关论文
共 50 条
  • [31] CORE1: Phase 2, single-arm study of CG0070 combined with pembrolizumab in patients with nonmuscle-invasive bladder cancer (NMIBC) unresponsive to bacillus Calmette-Guerin (BCG).
    Li, Roger
    Steinberg, Gary D.
    Uchio, Edward M.
    Lamm, Donald L.
    Shah, Paras
    Kamat, Ashish M.
    Bivalacqua, Trinity
    Packiam, Vignesh T.
    Chisamore, Michael Jon
    McAdory, John
    Grandi, Paola
    Hnat, Nataliya
    Burke, James
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [32] The current landscape of salvage therapies for patients with bacillus Calmette-Guerin unresponsive nonmuscle invasive bladder cancer
    Packiam, Vignesh T.
    Richards, Jordan
    Schmautz, Maximilian
    Heidenreich, Axel
    Boorjian, Stephen A.
    [J]. CURRENT OPINION IN UROLOGY, 2021, 31 (03) : 178 - 187
  • [33] KEYNOTE-676 cohort B: Randomized comparator-controlled cohort to evaluate efficacy and safety of pembrolizumab (pembro) plus bacillus Calmette-Guerin (BCG) in patients with high-risk BCG treatment-naive non-muscle invasive bladder cancer (HR NMIBC)
    Shariat, S. F.
    Steinberg, G.
    Kamat, A. M.
    Shore, N. D.
    Alanee, S.
    Nishiyama, H.
    Nam, K.
    Godwin, J. L.
    Kapadia, E.
    Hahn, N.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S723 - S723
  • [34] A phase II, randomized study of nivolumab (NIVO), NIVO plus linrodostat mesylate, or NIVO plus intravesical bacillus Calmette-Guerin (BCG) in BCG-unresponsive, high-risk, nonmuscle invasive bladder cancer (NMIBC): CheckMate 9UT.
    Hahn, Noah M.
    Chang, Sam
    Meng, Maxwell
    Shore, Neal D.
    Konety, Badrinath R.
    Steinberg, Gary D.
    Gschwend, Juergen
    Nishiyama, Hiroyuki
    Palou, Joan
    Taylor, John A.
    Lambert, Alexandre
    Zhu, Li
    Maeda, Toshiki
    Raybold, Bradley
    Fischer, Bruce S.
    Jeyamohan, Chandrika
    Zardavas, Dimitrios
    Witjes, Fred
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [35] CG0070 for the treatment of non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG)
    Uchio, Edward M.
    Li, Roger
    Steinberg, Gary
    Lamm, Donald
    Kamat, Ashish
    Packiam, Vignesh
    Anderson, Paul
    Ku, Ja Hyeon
    Chisamore, Michael
    McAdory, John
    Hnat, Nataliya
    Kim, Jee-Hyun
    Grandi, Paola
    Burke, James
    [J]. CANCER SCIENCE, 2023, 114 : 1587 - 1587
  • [36] CG0070 for the treatment of non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG)
    Li, R.
    Uchio, E.
    Steinberg, G. D.
    Shore, N.
    Anderson, P. D.
    Ben, T.
    Kamat, A.
    Keel, M.
    Packiam, V.
    McAdory, J.
    Kim, J. H.
    Chisamore, M.
    Grandi, P.
    Burke, J.
    [J]. HUMAN GENE THERAPY, 2021, 32 (19-20) : A130 - A130
  • [37] Effectiveness of the Moreau strain of Bacillus Calmette-Guerin (BCG) for nonmuscle invasive bladder cancer.
    Chade, Daher Cezar
    Machado, Andre
    Waksman, Ricardo
    Garcia, Guilherme
    Esteves, Paulo
    Adonias, Sanarelly
    Botelho, Luis
    Cordeiro, Mauricio
    Murta, Claudio
    Ribeiro-Filho, Leopoldo
    Sarkis, Alvaro
    Bastos, Diogo Assed
    Dzik, Carlos
    Srougi, Miguel
    Nahas, William Carlos
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [38] Maintenance bacillus Calmette-Guerin in high-risk nonmuscle-invasive bladder cancer - How much is enough?
    Decobert, Marc
    LaRue, Helene
    Harel, Francois
    Meyer, Francois
    Fradet, Yves
    Lacombe, Louis
    [J]. CANCER, 2008, 113 (04) : 710 - 716
  • [39] A randomized phase II study of erdafitinib (ERDA) versus intravesical chemotherapy (IC) in patients with high-risk nonmuscle invasive bladder cancer (HR-NMIBC) with FGFR mutations or fusions, who recurred after Bacillus Calmette-Guerin (BCG) therapy
    Steinberg, Gary D.
    Palou-Redorta, Joan
    Gschwend, Juergen E.
    Ben Tran
    Loriot, Yohann
    Daneshmand, Siamak
    Roupret, Morgan
    Santiago-Walker, Ademi E.
    Switzky, Julie C.
    Major, Christopher
    Baig, Mahadi
    Xia, Qi
    Catto, James W. F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [40] Pembrolizumab for the Treatment of Patients With Bacillus Calmette-Guerin-Unresponsive, High-Risk Non-Muscle-Invasive Bladder Cancer: Over 2 Years' Follow-Up of KEYNOTE-057.
    Krieger, Laurence Eliot Miles
    Balar, Arjun Vasant
    Ashish, Kamat
    Kulkarni, Girish S.
    Uchio, Edward M.
    Boormans, Joost L.
    Bajorin, Dean F.
    Roumiguie, Mathieu
    Singer, Eric A.
    Grivas, Petros
    Seo, Ho Kyung
    Hiroyuki, Nishiyama
    Konety, Badrinath R.
    Zambon, Joao Paulo
    Ekta, Kapadia
    de Wit, Ronald
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2020, 16 : 47 - 47
12345